These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 26267319)
1. RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop. Giladi ND; Ziv-Av A; Lee HK; Finniss S; Cazacu S; Xiang C; Waldman Ben-Asher H; deCarvalho A; Mikkelsen T; Poisson L; Brodie C Oncotarget; 2015 Sep; 6(26):22680-97. PubMed ID: 26267319 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687 [TBL] [Abstract][Full Text] [Related]
3. RTVP-1 regulates glioma cell migration and invasion via interaction with N-WASP and hnRNPK. Ziv-Av A; Giladi ND; Lee HK; Cazacu S; Finniss S; Xiang C; Pauker MH; Barda-Saad M; Poisson L; Brodie C Oncotarget; 2015 Aug; 6(23):19826-40. PubMed ID: 26305187 [TBL] [Abstract][Full Text] [Related]
4. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells. Rosenzweig T; Ziv-Av A; Xiang C; Lu W; Cazacu S; Taler D; Miller CG; Reich R; Shoshan Y; Anikster Y; Kazimirsky G; Sarid R; Brodie C Cancer Res; 2006 Apr; 66(8):4139-48. PubMed ID: 16618735 [TBL] [Abstract][Full Text] [Related]
5. Cloning and characterization of human RTVP-1b, a novel splice variant of RTVP-1 in glioma cells. Xiang C; Sarid R; Cazacu S; Finniss S; Lee HK; Ziv-Av A; Mikkelsen T; Brodie C Biochem Biophys Res Commun; 2007 Oct; 362(3):612-8. PubMed ID: 17825796 [TBL] [Abstract][Full Text] [Related]
6. RTVP-1 expression is regulated by SRF downstream of protein kinase C and contributes to the effect of SRF on glioma cell migration. Ziv-Av A; Taller D; Attia M; Xiang C; Lee HK; Cazacu S; Finniss S; Kazimirsky G; Sarid R; Brodie C Cell Signal; 2011 Dec; 23(12):1936-43. PubMed ID: 21777672 [TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells. Yang L; Guo H; Dong L; Wang L; Liu C; Wang X Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314 [TBL] [Abstract][Full Text] [Related]
9. HMGA2 sustains self-renewal and invasiveness of glioma-initiating cells. Zhong X; Liu X; Li Y; Cheng M; Wang W; Tian K; Mu L; Zeng T; Liu Y; Jiang X; Yu L; Gao L; Zhou Y Oncotarget; 2016 Jul; 7(28):44365-44380. PubMed ID: 27259253 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway. Hossain A; Gumin J; Gao F; Figueroa J; Shinojima N; Takezaki T; Priebe W; Villarreal D; Kang SG; Joyce C; Sulman E; Wang Q; Marini FC; Andreeff M; Colman H; Lang FF Stem Cells; 2015 Aug; 33(8):2400-15. PubMed ID: 25966666 [TBL] [Abstract][Full Text] [Related]
11. A novel interaction of PAK4 with PPARγ to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma. Kesanakurti D; Maddirela D; Banasavadi-Siddegowda YK; Lai TH; Qamri Z; Jacob NK; Sampath D; Mohanam S; Kaur B; Puduvalli VK Oncogene; 2017 Sep; 36(37):5309-5320. PubMed ID: 28534509 [TBL] [Abstract][Full Text] [Related]
12. Phospholipid scramblase 1 acts through the IL-6/JAK/STAT3 pathway to promote the malignant progression of glioma. Zhou S; Xu J; Zhu Y Arch Biochem Biophys; 2024 Jun; 756():110002. PubMed ID: 38636689 [TBL] [Abstract][Full Text] [Related]
13. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells. Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045 [TBL] [Abstract][Full Text] [Related]
14. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells. Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773 [TBL] [Abstract][Full Text] [Related]
15. Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling. Yin J; Oh YT; Kim JY; Kim SS; Choi E; Kim TH; Hong JH; Chang N; Cho HJ; Sa JK; Kim JC; Kwon HJ; Park S; Lin W; Nakano I; Gwak HS; Yoo H; Lee SH; Lee J; Kim JH; Kim SY; Nam DH; Park MJ; Park JB Cancer Res; 2017 Sep; 77(18):4973-4984. PubMed ID: 28754668 [TBL] [Abstract][Full Text] [Related]
16. The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma. Lee DW; Ramakrishnan D; Valenta J; Parney IF; Bayless KJ; Sitcheran R PLoS One; 2013; 8(2):e57489. PubMed ID: 23451236 [TBL] [Abstract][Full Text] [Related]